Activity ID
7958Expires
August 30, 2024Format Type
Journal-basedCME Credit
1Fee
$30CME Provider: JAMA Otolaryngology – Head & Neck Surgery
Description of CME Course
Responding to the coronavirus disease 2019 (COVID-19) pandemic necessitated resource redistribution and disrupted health care access. Several groups offered recommendations to safeguard head and neck oncologic care in this setting. Patients with advanced head and neck cancers were prioritized. In cases of clinical equipoise, nonsurgical treatment modalities were preferred
Disclaimers
1. This activity is accredited by the American Medical Association.
2. This activity is free to AMA members.
ABMS Member Board Approvals by Type
ABMS Lifelong Learning CME Activity
Allergy and Immunology
Anesthesiology
Colon and Rectal Surgery
Family Medicine
Medical Genetics and Genomics
Nuclear Medicine
Ophthalmology
Orthopaedic Surgery
Pathology
Physical Medicine and Rehabilitation
Plastic Surgery
Preventive Medicine
Psychiatry and Neurology
Radiology
Thoracic Surgery
Urology
Commercial Support?
NoNOTE: If a Member Board has not deemed this activity for MOC approval as an accredited CME activity, this activity may count toward an ABMS Member Board’s general CME requirement. Please refer directly to your Member Board’s MOC Part II Lifelong Learning and Self-Assessment Program Requirements.
Educational Objectives
To identify the key insights or developments described in this article
Keywords
Head and Neck Cancer, Head and Neck Surgery, Laryngology, Oncology, Otolaryngology
Competencies
Medical Knowledge
CME Credit Type
AMA PRA Category 1 Credit
DOI
10.1001/jamaoto.2021.2019